化学疗法诱导的多塞塔塞尔脱发症:流行率,治疗和预防
Aleymi M Perez1,2, Nicole I Haberland1,3, Mariya Miteva1
1Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, Miller School of Medicine, University of Miami, Miami, FL 33136, USA.
Current oncology (Toronto, Ont.)
|September 27, 2024
概括
多塞塔塞尔化疗可以导致显著的脱发,称为化疗诱导的脱发症 (CIA). 这篇评论涵盖了CIA的流行,预防策略,如头皮冷却,以及促进头发再生的治疗方法.
科学领域:
- 在瘤学瘤学.
- 皮肤病学 皮肤病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 多塞塔克塞尔是治疗各种癌症的重要化疗剂.
- 杜塞塔塞尔诱导的脱发 (CIA) 对患者的生活质量和治疗坚持产生负面影响.
- 持续性或永久性CIA (pCIA) 可能发生,在这种情况下,化学疗法后的头发不会完全再生.
研究的目的:
- 审查dcetaxel诱导的CIA和pCIA的流行情况.
- 讨论中情局目前的预防和管理策略.
- 为了突出CIA正在进行的研究和实验模型.
主要方法:
- 对多塞塔克塞尔诱导的脱发症的文献综述.
- 分析当前的预防标准 (例如,头皮冷却).
- 对CIA新兴治疗方法和研究模型的概述.
主要成果:
- 多塞塔克塞尔显著影响头皮毛囊,导致CIA.
- 头皮冷却是中央情报局预防的既定标准.
- 米诺西迪尔,PBMT和PRP是治疗头发再生的治疗方法之一,目前正在进行临床试验,探索新的药物.
结论:
- 杜塞塔克塞尔诱导的CIA是一种常见且具有影响力的副作用.
- 有效的预防和管理策略对于患者的福祉至关重要.
- 先进的研究模型对于开发更好的CIA干预至关重要.
相关概念视频
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
181
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
181
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
153
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
153
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
236
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
236
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K


